The EURETINA meeting featured new treatments in gene therapy and innovative implants to enhance patient quality of life.
Frank Holz, MD, FEBO, FARVO
Advertisement
Articles by Frank Holz, MD, FEBO, FARVO
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Modern Retina
1
Q&A: Evolving approaches to geographic atrophy management
2
First patient treated in dose-expansion portion of SpliceBio's phase 1/2 ASTRA clinical trial
3
Exploring Emerging Therapies in the Retinal Vascular Disease Pipeline
4
Nanoscope secures new US patent for Multi-Characteristic Opsin (MCO) technology platform
5